Ophthalmology therapies, non-invasive ocular therapies
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
190
NCT04761705
Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 10, 2021
Completion: Jul 31, 2025
NCT06751355
Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Phase: N/A
Role: Collaborator
Start: Feb 25, 2025
Completion: May 31, 2026
NCT06898203
Precision Imaging to Evaluate Kaposi Sarcoma
Start: Mar 28, 2025
Completion: Nov 30, 2029
Loading map...